CN101380328A - Medicine for treating coryza and its preparation method - Google Patents
Medicine for treating coryza and its preparation method Download PDFInfo
- Publication number
- CN101380328A CN101380328A CNA2007100126599A CN200710012659A CN101380328A CN 101380328 A CN101380328 A CN 101380328A CN A2007100126599 A CNA2007100126599 A CN A2007100126599A CN 200710012659 A CN200710012659 A CN 200710012659A CN 101380328 A CN101380328 A CN 101380328A
- Authority
- CN
- China
- Prior art keywords
- medicine
- dissolved
- units
- rhinitis
- mixed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A drug for treating rhinitis and a preparation method thereof relate to an improved drug for treating the rhinitis. The invention provides the drug for treating the rhinitis and the preparation method thereof. The drug contains 1.6 million units of penicillin sodium salt, 6-9mg of hydrocortisone and 4-7mg of dexamethasone sodium phosphate according to weight proportion. The preparation method is characterized by comprising the following steps: (1) 0.8 million units of the penicillin sodium salt and 6-9mg of the hydrocortisone are mixed and dissolved; (2) 0.8 million units of the penicillin sodium salt and 4-7mg of the dexamethasone sodium phosphate are mixed and dissolved; and (3) the two mixed solutions are mixed to prepare the drug for treating the rhinitis.
Description
Technical field:
The present invention relates to a kind of improvement for the treatment of the medicine of rhinitis.
Background technology:
Rhinitis is a kind of commonly encountered diseases, frequently-occurring disease.Rhinitis has allergic rhinitis, chronic rhinitis, atrophic rhinitis etc. multiple.At present, the medicine of treatment rhinitis also has multiple, but all can not fundamentally cure; Rhinitis also can adopt operative treatment, but may produce a little sequela etc.
Summary of the invention:
The present invention is exactly at the problems referred to above, and a kind of medicine of curing rhinitis and preparation method thereof is provided.
To achieve these goals, the present invention adopts following technical scheme, the present invention includes penicillin sodium, hydrocortisone, dexamethasone sodium phosphate, and each constituent content is by weight:
Penicillin sodium 1,600,000 units;
Hydrocortisone 6～9mg;
Dexamethasone sodium phosphate 4～7mg.
The preparation method of medicine of the present invention is characterized in that may further comprise the steps:
(1), get the penicillin sodium of 800,000 units, the hydrocortisone of 6～9mg, its mixing is dissolved;
(2), get the penicillin sodium of 800,000 units, the dexamethasone sodium phosphate of 4～7mg, its mixing is dissolved;
(3), two kinds of mixed solutions are mixed, promptly get medicine of the present invention.
Beneficial effect of the present invention:
Medicine of the present invention can fundamentally be cured rhinitis; Also can avoid the sequela etc. of performing the operation.
The specific embodiment:
Embodiment 1:
Get the penicillin sodium of 800,000 units, the hydrocortisone of 6mg, its mixing is dissolved; Get the penicillin sodium of 800,000 units, the dexamethasone sodium phosphate of 4mg again, its mixing is dissolved; At last two kinds of mixed solutions are mixed, promptly get medicine of the present invention.
Embodiment 2:
Get the penicillin sodium of 800,000 units, the hydrocortisone of 7mg, its mixing is dissolved; Get the penicillin sodium of 800,000 units, the dexamethasone sodium phosphate of 5mg again, its mixing is dissolved; At last two kinds of mixed solutions are mixed, promptly get medicine of the present invention.
Embodiment 3:
Get the penicillin sodium of 800,000 units, the hydrocortisone of 8mg, its mixing is dissolved; Get the penicillin sodium of 800,000 units, the dexamethasone sodium phosphate of 6mg again, its mixing is dissolved; At last two kinds of mixed solutions are mixed, promptly get medicine of the present invention.
Embodiment 4:
Get the penicillin sodium of 800,000 units, the hydrocortisone of 9mg, its mixing is dissolved; Get the penicillin sodium of 800,000 units, the dexamethasone sodium phosphate of 7mg again, its mixing is dissolved; At last two kinds of mixed solutions are mixed, promptly get medicine of the present invention.
Medicine of the present invention is the Western medicine complexing agent, is the liquid that is watery.
During use, medicine of the present invention is splashed into nasal cavity or spray into nasal cavity (to spray into best results).
Medicine of the present invention is in line with sick the lighter usefulness less, the principle that seriously ill person uses more; The medication in preceding 1～2 hour of liking to sleep most.
Light patient's medication is after 24 hours, and visible obvious effects was fully recovered in one month.
Clinical data:
1, Yu Yanqing: the woman, 47 years old, suffer from rhinitis and had a surplus in 10 years; After using medicine of the present invention to treat half a year continuously, recovery from illness;
2, Niu Qing: the man, 45 years old, suffered from rhinitis 4 years; After using medicine of the present invention to treat one month continuously, recovery from illness;
3, Li Xiang: the man, 50 years old, suffered from rhinitis 30 years; After using medicine of the present invention to treat half a year continuously, recovery from illness.
Claims (6)
1, a kind of medicine for the treatment of rhinitis is characterized in that comprising penicillin sodium, hydrocortisone, dexamethasone sodium phosphate, and each constituent content is by weight:
Penicillin sodium 1,600,000 units;
Hydrocortisone 6～9mg;
Dexamethasone sodium phosphate 4～7mg.
2, a kind of preparation method for the treatment of the medicine of rhinitis is characterized in that may further comprise the steps:
(1), get the penicillin sodium of 800,000 units, the hydrocortisone of 6～9mg, its mixing is dissolved;
(2), get the penicillin sodium of 800,000 units, the dexamethasone sodium phosphate of 4～7mg, its mixing is dissolved;
(3), two kinds of mixed solutions are mixed, promptly get medicine of the present invention.
3, a kind of medicine for the treatment of rhinitis according to claim 1 and 2 and preparation method thereof is characterized in that getting the penicillin sodium of 800,000 units, the hydrocortisone of 6mg, and its mixing is dissolved; Get the penicillin sodium of 800,000 units, the dexamethasone sodium phosphate of 4mg again, its mixing is dissolved; At last two kinds of mixed solutions are mixed, promptly get medicine of the present invention.
4, a kind of medicine for the treatment of rhinitis according to claim 1 and 2 and preparation method thereof is characterized in that getting the penicillin sodium of 800,000 units, the hydrocortisone of 7mg, and its mixing is dissolved; Get the penicillin sodium of 800,000 units, the dexamethasone sodium phosphate of 5mg again, its mixing is dissolved; At last two kinds of mixed solutions are mixed, promptly get medicine of the present invention.
5, a kind of medicine for the treatment of rhinitis according to claim 1 and 2 and preparation method thereof is characterized in that getting the penicillin sodium of 800,000 units, the hydrocortisone of 8mg, and its mixing is dissolved; Get the penicillin sodium of 800,000 units, the dexamethasone sodium phosphate of 6mg again, its mixing is dissolved; At last two kinds of mixed solutions are mixed, promptly get medicine of the present invention.
6, a kind of medicine for the treatment of rhinitis according to claim 1 and 2 and preparation method thereof is characterized in that getting the penicillin sodium of 800,000 units, the hydrocortisone of 9mg, and its mixing is dissolved; Get the penicillin sodium of 800,000 units, the dexamethasone sodium phosphate of 7mg again, its mixing is dissolved; At last two kinds of mixed solutions are mixed, promptly get medicine of the present invention.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007100126599A CN101380328B (en) | 2007-09-03 | 2007-09-03 | Medicine for treating coryza and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007100126599A CN101380328B (en) | 2007-09-03 | 2007-09-03 | Medicine for treating coryza and its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101380328A true CN101380328A (en) | 2009-03-11 |
| CN101380328B CN101380328B (en) | 2010-08-04 |
Family
ID=40460501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007100126599A Expired - Fee Related CN101380328B (en) | 2007-09-03 | 2007-09-03 | Medicine for treating coryza and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101380328B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160193286A1 (en) * | 2012-12-27 | 2016-07-07 | Massachusetts Eye & Ear Infirmary | Treatment of Rhinosinusitis with P-glycoprotein Inhibitors |
| US11408900B2 (en) | 2016-01-15 | 2022-08-09 | Massachusetts Eye And Ear Infirmary | Secreted P-glycoprotein is a non-invasive biomarker of chronic rhinosinusitis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1222351A (en) * | 1998-12-11 | 1999-07-14 | 陈振钰 | Compound nose drop |
| CN1265890A (en) * | 2000-02-14 | 2000-09-13 | 刘嘉 | Anti-anaphylaxis nose-drop |
| CN1288727A (en) * | 2000-08-07 | 2001-03-28 | 汪帝钧 | Composite medicine for rhinitis and its application |
| CN1378841A (en) * | 2001-04-07 | 2002-11-13 | 乌鲁木齐市头屯河区高尔康财团制药厂 | Medicine for treating rhinitis |
| CN1709423A (en) * | 2005-06-06 | 2005-12-21 | 广东医学院 | Medicinal formulation of glucocorticoid and Chinese medicine for preventing and treating asthma and COPD |
-
2007
- 2007-09-03 CN CN2007100126599A patent/CN101380328B/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160193286A1 (en) * | 2012-12-27 | 2016-07-07 | Massachusetts Eye & Ear Infirmary | Treatment of Rhinosinusitis with P-glycoprotein Inhibitors |
| US9744210B2 (en) * | 2012-12-27 | 2017-08-29 | Massachusetts Eye & Ear Infirmary | Treatment of rhinosinusitis with P-glycoprotein inhibitors |
| US10653745B2 (en) | 2012-12-27 | 2020-05-19 | Massachusetts Eye And Ear Infirmary | Treatment of rhinosinusitis with P-glycoprotein inhibitors |
| US11007246B2 (en) | 2012-12-27 | 2021-05-18 | Massachusetts Eye And Ear Infirmary | Treatment of rhinosinusitis with P-glycoprotein inhibitors |
| US11786574B2 (en) | 2012-12-27 | 2023-10-17 | Massachusetts Eye And Ear Infirmary | Treatment of rhinosinusitis with p-glycoprotein inhibitors |
| US11408900B2 (en) | 2016-01-15 | 2022-08-09 | Massachusetts Eye And Ear Infirmary | Secreted P-glycoprotein is a non-invasive biomarker of chronic rhinosinusitis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101380328B (en) | 2010-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102172356B (en) | Use of taurochenodeoxycholic acid in prevention and treatment of osteoporosis | |
| RU2010121827A (en) | COMPOSITIONS FOR TREATING PARKINSON'S DISEASE | |
| CN100536901C (en) | Chinese medicine for treating burn, scald and frostbite | |
| CN101380328B (en) | Medicine for treating coryza and its preparation method | |
| WO2015024420A1 (en) | Local anesthesia pain-relieving time-delay agent | |
| CN106667903A (en) | Fluoxetine tincture for treating leucoderma | |
| CN101675952B (en) | Patch for prevention and control of bronchial asthma | |
| CN1660256A (en) | Medication for treating cough caused by inflammation of upper respiratory tract | |
| Zhou et al. | Research progress on the treatment of knee osteoarthritis combined with osteoporosis by single-herb Chinese medicine and compound | |
| CN102228597A (en) | Medicament for treating oral ulcer and preparation method | |
| CN1843366A (en) | Burn-treating liquid | |
| CN112957350A (en) | A herba Houttuyniae aerosol inhalation solution and its preparation method | |
| CN1086126C (en) | Prednelan composition for treating rheumatism | |
| CN101152328A (en) | Traditional Chinese medicine for treating nasal obstruction of chronic rhinitis | |
| CN101919799B (en) | Novel sustained-release transdermal medicament delivery system | |
| CN104224800A (en) | Medicine for treating rhinitis and preparation method thereof | |
| CN100464780C (en) | Hot compress medicine for treating omitis, and its preparing method | |
| CN101167917A (en) | Traditional Chinese medicine for treating aural vertigo | |
| CN101002833A (en) | Medicine for treating psoriasis | |
| CN1951440A (en) | Chinese medicinal lotion prescription for treating psoriasis | |
| CN101152451A (en) | Traditional Chinese medicine for treating pregnancy aphonia | |
| CN101152225A (en) | Traditional Chinese medicine for treating ancylostomiasis | |
| CN1965860A (en) | Acupoints applied medicament for treating insomnia and preparation process thereof | |
| CN101112413A (en) | Traditional Chinese medicine special for treating periodontitis | |
| CN1259354A (en) | External use medicinal liquid for treating psoriasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100804 Termination date: 20120903 |